Tscan Therapeutics, Inc. · NASDAQ:TCRX
MacBeath Gavin received 1,000,000 Tscan Therapeutics, Inc. shares as an award (Form 4)
Traded Oct 1, 2026 · Filed Oct 2, 2026
On Oct 1, 2026, MacBeath Gavin (Director, Chief Executive Officer) received 1,000,000 Tscan Therapeutics, Inc. shares as an award, leaving 1,049,767 shares. Filed Oct 2, 2026 (Form 4).
- Awarded
- 1,000,000 shares
- Holding after
- 1,049,767 shares
- Trading plan
- No
- Role
- Director, Chief Executive Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Oct 1, 2026 | Voting Common Stock | Award | 1,000,000 | 1,049,767 | Direct |
Source
Related
- Tscan Therapeutics, Inc.
- MacBeath Gavin
- Tscan Therapeutics, Inc. shareholders
- Form 4 · Zdraveski Zoran · Oct 2, 2026
- Schedule 13G · Readout Capital, LP · Sep 25, 2026
- Schedule 13G/A · Lynx1 Capital Management LP · Aug 14, 2026
- Schedule 13G/A · Biotechnology Value Fund L P · Aug 14, 2026
- Schedule 13G/A · Biotechnology Value Fund L P · May 15, 2026